SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-082817
Filing Date
2021-03-16
Accepted
2021-03-16 16:15:53
Documents
1
Period of Report
2021-03-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d228038d8k.htm 8-K 17344
  Complete submission text file 0001193125-21-082817.txt   18552
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 21745893
SIC: 2836 Biological Products, (No Diagnostic Substances)